72 related articles for article (PubMed ID: 9070877)
1. Overexpression of SAP-1, a transmembrane-type protein tyrosine phosphatase, in human colorectal cancers.
Seo Y; Matozaki T; Tsuda M; Hayashi Y; Itoh H; Kasuga M
Biochem Biophys Res Commun; 1997 Feb; 231(3):705-11. PubMed ID: 9070877
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.
Nagano H; Noguchi T; Inagaki K; Yoon S; Matozaki T; Itoh H; Kasuga M; Hayashi Y
Oncogene; 2003 Jul; 22(30):4656-63. PubMed ID: 12879010
[TBL] [Abstract][Full Text] [Related]
3. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
4. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
[TBL] [Abstract][Full Text] [Related]
5. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
6. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
7. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
[TBL] [Abstract][Full Text] [Related]
8. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger protein OZF (ZNF146) is overexpressed in colorectal cancer.
Ferbus D; Bovin C; Validire P; Goubin G
J Pathol; 2003 Jun; 200(2):177-82. PubMed ID: 12754738
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
Cardillo MR; Yap EP
Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
[TBL] [Abstract][Full Text] [Related]
11. A novel gene containing PDZ and LIM domains, PCD1, is overexpressed in human colorectal cancer.
Furuya M; Tsuji N; Endoh T; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6C):4183-6. PubMed ID: 12553053
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
[TBL] [Abstract][Full Text] [Related]
13. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
14. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
17. Quantitative tissue carcinoembryonic antigen (T CEA) assay as a screening test for severe dysplasia in colorectal adenomas.
Rosandić M; Skegro M; Paar V; Paar D; Sćukanec-Spoljar M; Juricić M; Vucelić B; Pulanić R; Rustemović N; Ostojić R; Ljubojević N
Acta Med Austriaca; 1999; 26(3):89-92. PubMed ID: 10520376
[TBL] [Abstract][Full Text] [Related]
18. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
20. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
